Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease

231Citations
Citations of this article
142Readers
Mendeley users who have this article in their library.

Abstract

Patients with compensated advanced chronic liver disease (cACLD) can safely avoid screening endoscopy with a platelet count >150 × 109 cells/L and a liver stiffness measurement (LSM) <20 kPa (Baveno VI criteria). However, the total number of avoided endoscopies using this rule is relatively low. We aimed at expanding the Baveno VI criteria and validating them in additional cohorts. Patients from the Anticipate cohort (499 patients with cACLD of different etiologies) were used to study the performance of different thresholds of platelets and LSM for the identification of patients at very low risk (<5%) of having varices needing treatment (VNT). The new criteria (Expanded-Baveno VI) were validated in two additional cohorts from London (309 patients) and Barcelona (117 patients). The performance of the new criteria by etiology of cACLD was also assessed. The best new expanded classification rule was platelet count >110 × 109 cells/L and LSM <25 kPa. This was validated in the two additional cohorts. Overall, the Expanded-Baveno VI criteria would potentially spare 367 (40%) endoscopies (21% with Baveno VI criteria) with a risk of missing VNT of 1.6% (95% confidence interval, 0.7%-3.5%) in patients within the criteria and 0.6% (95% confidence interval, 0.3%-1.4%) in the overall population of 925 patients evaluated. The Expanded-Baveno VI criteria performed well in patients with cACLD with hepatitis C virus and alcoholic and nonalcoholic steatohepatitis. Conclusion: The new Expanded-Baveno VI criteria spare more endoscopies than the original criteria with a minimal risk of missing VNT in most of the main etiologies of cACLD. (Hepatology 2017;66:1980–1988).

References Powered by Scopus

Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension

2776Citations
N/AReaders
Get full text

Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

2448Citations
N/AReaders
Get full text

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

1557Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Liver cirrhosis

842Citations
N/AReaders
Get full text

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

774Citations
N/AReaders
Get full text

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

572Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Augustin, S., Pons, M., Maurice, J. B., Bureau, C., Stefanescu, H., Ney, M., … Genescà, J. (2017). Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology, 66(6), 1980–1988. https://doi.org/10.1002/hep.29363

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 48

58%

Researcher 19

23%

Professor / Associate Prof. 12

14%

Lecturer / Post doc 4

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 87

91%

Biochemistry, Genetics and Molecular Bi... 5

5%

Nursing and Health Professions 3

3%

Neuroscience 1

1%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 16

Save time finding and organizing research with Mendeley

Sign up for free